U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 2

1.
Figure 2

Figure 2. From: Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.

Differences in pre-treatment QoL between 3-month surviviors vs. non-survivors. a )EORTC QLQ-C15-PAL: physical function (higher score better), fatigue and pain (both: higher score worse). b) EORTC BN20: motor dysfunction, headaches and hairloss (higher score worse) (*p < .05, ** p < .01, ***p < .001; paired-t-test, one-tailed).

Diana Steinmann, et al. BMC Cancer. 2012;12:283-283.
2.
Figure 1

Figure 1. From: Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.

Self-assessed QoL in preselected QLQ scales before and 3 months after start of RT. a) EORTC QLQ C15-PAL: global QoL, physical function (higher score better), and fatigue (higher score worse). b) EORTC BN20: motor dysfunction, headaches and hairloss (all higher score worse) (*p < .05, ** p < .01, ***p < .001; paired-t-test, one-tailed).

Diana Steinmann, et al. BMC Cancer. 2012;12:283-283.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center